Gene Therapy Gets Orphan Drug Designation in US and Europe – Rare Disease Report
|
Gene Therapy Gets Orphan Drug Designation in US and Europe
Rare Disease Report This morning, Paris-based biotech Vivet Therapeutics announced that its lead gene therapy product VTX-801 has been granted Orphan Drug Designation by both the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the … |
